High throughput ribonuclease protection assay for the determination of CYP3A mRNA induction in cultured rat hepatocytes

Xenobiotica

Volumn 29, Issue 8, 1999, Pages 827-838

  Surry, D D ^a   McAllister, G ^a   Meneses Lorente, G ^a   Evans, D C ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA CYANOPREGNENOLONE; BETA NAPHTHOFLAVONE; COMPLEMENTARY RNA; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; MATRIGEL; MESSENGER RNA; METHYLCLOFENAPATE; RIBONUCLEASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG RESEARCH; FEMALE; GENE INDUCTION; IN SITU HYBRIDIZATION; ISOTOPE LABELING; LIVER CELL CULTURE; NONHUMAN; RAT; RIBONUCLEASE PROTECTION ASSAY; RNA HYBRIDIZATION; RNA PROBE;

ALKANE 1-MONOOXYGENASE; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BETA-NAPHTHOFLAVONE; CELLS, CULTURED; CLOFENAPATE; CLONING, MOLECULAR; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; IN SITU HYBRIDIZATION; LIVER; MIXED FUNCTION OXYGENASES; OXIDOREDUCTASES, N-DEMETHYLATING; PREGNENOLONE CARBONITRILE; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEASES; RNA PROBES; RNA, MESSENGER; TETRAZOLIUM SALTS; TOXICITY TESTS;

EID: 0032849829     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238272     Document Type: Article

References (45)

1. BARS, R. G., MITCHELL, A. M., WOLF, C. R. and ELCOMBE, C. R., 1989, Induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localization of specific isoenzymes using immunocytochemistry induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localization of specific isoenzymes using immunocytochemistry. Biochemical Journal, 262, 151-158.
2. BELL, D. R., BARS, R. G. and ELCOMBE, C. R., 1992, Differential tissue-specific expression and induction of cytochrome P450IVA1 and acyl-CoA oxidase. European Journal of Biochemistry, 206, 979-986.
3. BELL, D. R. and ELCOMBE, C. R., 1991, Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators. Biochemical Journal, 280, 249-253.
4. CZERWINSKI, M., MCLEMORE, T. L., GELBOIN, H. V. and GONZALEZ, F. J., 1994, Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Research, 54, 1085-1091.
5. DALET, C., BLANCHARD, J. M., GUZELIAN, P., BARWICK, J., HARTLE, H. and MAUREL, P., 1986, Cloning of a cDNA coding for P-450 LM3c from rabbit liver microsomes and regulation of its expression. Nucleic Acids Research, 14, 5999-6015.
6. DENISON, M. S. and WHITLOCK, J. P., JR, 1995, Xenobiotic-inducible transcription of cytochrome P450 genes. Journal of Biological Chemistry, 270, 18175-18178.
7. DIAZ, D., FABRE, I., DAUJAT, M., SAINT AUBERT, B., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology, 99, 737-747.
8. EKINS, S., MURRAY, G. I., BURKE, M. D., WILLIAMS, J. A., MARCHANT, N. C. and HAWKSWORTH, G. M., 1995, Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug Metabolism and Disposition, 23, 1274-1279.
9. FUJII-KURIYAMA, Y., IMATAKA, H., SOGAWA, K., YASUMOTO, K. and KIKUCHI, Y., 1992, Regulation of CYP1A1 expression. FASEB Journal, 6, 706-710.
10. GAIDAMAKOVA, E. K., ALPATOV, O. V., ISCHENKO, I. V., KOVALENKO, S. P. and LYAKHOVICH, V., 1996, Phenobarbital-dependent protein binding to Barbie box-like sequences in the coding region of cytochrome P450BM-3 gene from Bacillus megaterium. Gene, 183, 97-101.
11. GONZALEZ, F. J., CRESPI, C. L., CZERWINSKI, M. and GELBOIN, H. V., 1992, Analysis of human cytochrome P450 catalytic activities and expression. Tohoku Journal of Experimental Medicine, 168, 67-72.
12. GORSKI, J. C., HALL, S. D., JONES, D. R., VANDENBRANDEN, M. and WRIGHTON, S. A., 1994, Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochemical Pharmacology, 47, 1643-1653.
13. GUENGERICH, F. P., 1988, Oxidation of 17alpha-ethynylestradiol by human liver cytochrome P-450. Molecular Pharmacology, 33, 500-508.
14. HARRIS, D. W., KENRICK, M. K., PITHER, R. J., ANSON, J. G. and JONES, D. A., 1996, Development of a high-volume in situ mRNA hybridization assay for the quantification of gene expression utilizing scintillating microplates. Analytical Biochemistry, 243, 249-256.
15. JONES, D. A., HARRIS, D. W., KENRICK, M. K. and THOMAS, N., 1997, High volume in-situ mRNA hybridization method for the quantification and discovery of disease specific genes. Patent WO 9740189 A1, 9710.
16. KIRITA, S. and MATSUBARA, T., 1993, cDNA cloning and characterization of a novel member of steroid-induced cytochrome P4503A in rats. Archives of Biochemistry and Biophysics, 307, 253-258.
17. KLIEWER, S. A., MOORE, J. T., WADE, L., STAUDINGER, J. L., WATSON, M. A., JONES, S. A., MCKEE, D. D., OLIVER, B. B., WILLSON, T. M., ZETTERSTROM, R. H., PERLMANN, T. and LEHMANN, J. M., 1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell (Cambridge, MA), 92, 73-82.
18. KOCAREK, T. A., SCHUETZ, E. G., STROM, S. C., FISHER, R. A. and GUZELIAN, P. S., 1995, Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition, 23, 415-421.
19. KOSTRUBSKY, V. E., STROM, S. C., WOOD, S. G., WRIGHTON, S. A., SINCLAIR, P. R. and SINCLAIR, J. F., 1995, Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Archives of Biochemistry and Biophysics, 322, 516-520.
20. LEHMANN. J. M., MCKEE, D. D., WATSON, M. A., WILLSON, T. M., MOORE, J. T. and KLIEWER, S. A., 1998, The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3 A4 gene expression and cause drug interactions. Journal of Clinical Investigation, 102, 1016-1023.
21. LIANG, Q., HE, J.-S. and FULCO, A. J., 1995, The role of Barbie box sequences as cis-acting elements involved in the barbiturate-mediated induction of cytochromes P450BM-1 and P450BM-3 in Bacillus megaterium. Journal of Biological Chemistry, 270, 4438-4450.
22. LURINTSKI, J., FLINT, O. P. and DURHAM, S. K., 1994, In vivo and in vitro studies of rat liver cytochrome P450 induction: III. In vitro effect of BMS-181168 on cytochrome P450-dependent activities in primary culture of rat hepatocytes. In vitro Toxicology, 7, 25-31.
23. MAHNKE, A., STROTKAMP, D., ROOS, P. H., HANSTEIN, W. G., CHABOT, G. G. and NEF, P., 1997, Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Archives of Biochemistry and Biophysics, 337, 62-68.
24. MAKOWSKA, J. M., BONNER, F. W. and GIBSON, G. G., 1990, Hepatic induction potency of hypolipidemic drugs in the rat following long-term administration: influence of different dosing regimens. Xenobiotica, 20, 1121-1128.
25. MICHALETS, E. L., 1998, Update: clinically significant cytochrome P-450 drug interactions. Pharmaco-therapy, 18, 84-112.
26. MORRIS, D. L. and DAVILA, J. C., 1996, Analysis of rat cytochrome P450 isoenzyme expression using semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Biochemical Pharmacology, 52, 781-792.
27. NIMS, R. W., DEVOR, D. E., HENNEMAN, J. R. and LUBET, R. A., 1987, Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates. Carcinogenesis (London), 8, 67-71.
28. PARKINSON, A., 1996, An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials. Toxicology and Pathology, 24, 45-57.
29. PESSAYRE, D., DESCATOIRE, V., KONSTANTINOVA-MITCHEVA, M., WANDSCHEER, J. C., COBERT, B., LEVEL, R., BENHAMOU, J. P., JAQUEN, M. and MANSUY. D., 1981, Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450. Biochemical Pharmacology, 30, 553-558.
30. REESE, J. A. and BYARD, J. L., 1981, Isolation and culture of adult hepatocytes from liver biopsies. In vitro, 17, 935-940.
31. RYU, D.-Y., LEVI, P. E., FERNANDEZ-SALGUERO, P., GONZALEZ, F. J. and HODGSON, E., 1996, Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon response receptor knock-out mouse liver. Molecular Pharmacology, 50, 443-446.
32. SAFE, S. and KRISHNAN, V., 1995, Cellular and molecular biology of aryl hydrocarbon (Ah) receptormediated gene expression. Archives of Toxicology, 17(suppl.), 99-115.
33. SCHUETZ, E. G., LI, D., OMIECINSKI, C. J., MULLER-EBERHARD, U., KLEINMAN, H. K., ELSWICK, B. and GUZELIAN, P. S., 1988, Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. Journal of Cellular Physiology, 134, 309-323.
34. SCHUETZ, J. D., BEACH, D. L. and GUZELIAN, P. S., 1994, Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics, 4, 11-20.
35. SHARER, J. E., SHIPLEY, L. A., VANDENBRANDEN, M. R., BINKLEY, S. N. and WRIGHTON, S. A., 1995, Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition, 23, 1231-1241.
36. SIDHU, J. S. and OMIECINSKI, C. J., 1996, Forskolin-mediated induction of CYP3A1 mRNA expression in primary rat hepatocytes is independent of elevated intracellular cyclic AMP. Journal of Pharmacology and Experimental Therapeutics, 276, 238-245.
37. SMITH, D. A., 1994, Design of drugs through a consideration of drug metabolism and pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics, 19, 193-199.
38. SOGAWA, K., 1993, Mechanism of transcriptional regulation of the cytochrome P-450 1A1 gene. Jikken Igaku, 11, 949-953.
39. STRAYHOHN, V. A., BACIEWICZ, A. M. and SELF, T. H., 1997, Update on rifampin drug interactions, III. Archives of Internal Medicine, 157, 2453-2458.
40. STROM, S. C., JIRTLE, R. L., JONES, R. S., NOVICKI, D. L., ROSENBERG, M. R., NOVOTNY, A., IRONS, G., MCLAIN, J. R. and MICHALOPOULOS, G., 1982, Isolation, culture, and transplantation of human hepatocytes. Journal of the National Cancer Institute, 68, 771-778.
41. WADHWA, N. K., SCHROEDER, T. J., O'FLAHERTY, E., PESCE, A. J., MYRE, S. A., MUNDA, R. and FIRST, M. R., 1987, Interaction between erythromycin and cyclosporine in a kidney and pancreas allograft recipient. Therapeutic Drug Monitoring, 9, 123-125.
42. WILLEY, J. C., COY, E. L., FRAMPTON, M. W., TORRES, A., APOSTOLAKOS, M. J., HOEHN, G., SCHUERMANN, W. H., THILLY, W. G., OLSON, D. E., HAMMEHSLEY, J. R., CRESPI, C. L. and UTELL, M. J., 1997, Quantitative RT-PCR measurement of cytochromes P450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in-lung cells of smokers and nonsmokers. American Journal of Respiratory Cell and Molecular Biology, 17, 114-124.
43. WILLIAMS, J. A., CHENERY, R. J. and HAWKSWORTH, G. M., 1994, Induction of CYP3A enzymes in human and rat hepatocyte cultures. Biochemical Society Transactions, 22, 131S.
44. WORTELBOER, H. M., DE KRUIF, C. A., VAN IERSEL, A. A. J., FALKE, H. E., NOORDHOEK, J. and BLAAUBOER, B. J., 1991, Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures. The effects of model inducers on apoproteins and biotransformation activities. Biochemical Pharmacology, 42, 381-390.
45. WRIGHT, M. C., PAINE, A. J., SKETT, P. and AULD, R., 1994, Induction of rat hepatic glucocorticoid-inducible cytochrome P450 3A by metyrapone. Journal of Steroid Biochemistry and Molecular Biology, 48, 271-276.